Data as of Apr 15
| -0.01 / -0.80%|
The 1 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 4.53, with a high estimate of 4.53 and a low estimate of 4.53. The median estimate represents a +265.32% increase from the last price of 1.24.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.